Scientists have developed a promising new treatment that can cut “bad” cholesterol by nearly 50% — without using statins. The approach targets PCSK9, a key protein that limits the body’s ability to remove LDL cholesterol from the blood.
Using innovative DNA-based molecules called PPRHs, researchers blocked PCSK9 production, allowing more LDL receptors to clear cholesterol from circulation.
In lab and animal studies, a single dose significantly reduced cholesterol levels with fewer side effects.
If validated in humans, this could offer a safer, more targeted alternative for managing heart disease risk.
Read more at ScienceDaily